Medicure (MCUJF) Cash & Equivalents (2009 - 2026)

Medicure's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 77.56% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 77.56% YoY), while the FY2025 annual figure was $2.8 million, down 39.68% from the prior year.
• Cash & Equivalents was $1.1 million for Q1 2026 at Medicure, down from $2.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $5.2 million in Q3 2025 to a low of $1.1 million in Q1 2026.
• Historically, Cash & Equivalents has averaged $3.8 million across 5 years, with a median of $3.6 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Cash & Equivalents soared 71.49% in 2022, then plunged 77.56% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $2.7 million in 2022, then surged by 31.1% to $3.6 million in 2023, then advanced by 27.79% to $4.6 million in 2024, then sank by 39.68% to $2.8 million in 2025, then slumped by 59.11% to $1.1 million in 2026.
• The last three Cash & Equivalents figures came in at $1.1 million (Q1 2026), $2.8 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.